Hikma Pharmaceuticals (HIK) RNS Announcements

Add to Alert list
Date Time Source Announcement
13 Mar 2019 07:00 AM
RNS
Final Results
12 Mar 2019 07:00 AM
RNS
Directorate Change
01 Mar 2019 04:51 PM
RNS
Total Voting Rights
28 Feb 2019 09:00 AM
RNS
Hikma establishes partnership with Melinta in MENA
27 Feb 2019 01:26 PM
RNS
Block listing Interim Review
26 Feb 2019 11:08 AM
RNS
Notice of Results
11 Feb 2019 10:11 AM
RNS
Director/PDMR Shareholding
01 Feb 2019 03:43 PM
RNS
Total Voting Rights
29 Jan 2019 09:00 AM
RNS
Hikma launches Mitomycin for Injection
03 Jan 2019 09:00 AM
RNS
Hikma announces agreement with Sciecure Pharma
10 Dec 2018 09:00 AM
RNS
Hikma launches Clobazam
03 Dec 2018 10:30 AM
RNS
Total Voting Rights
27 Nov 2018 09:00 AM
RNS
Hikma announces injectable licensing agreement
19 Nov 2018 09:00 AM
RNS
Hikma launches Triazolam Tablets
13 Nov 2018 11:15 AM
RNS
Holding(s) in Company
08 Nov 2018 09:44 AM
RNS
Hikma announces agreement with Vectura
08 Nov 2018 07:00 AM
RNS
Hikma announces agreement with Vectura
08 Nov 2018 07:00 AM
RNS
Trading Statement
01 Nov 2018 12:39 PM
RNS
Total Voting Rights
16 Oct 2018 04:30 PM
RNS
Block listing Interim Review
01 Oct 2018 10:53 AM
RNS
Total Voting Rights
01 Oct 2018 10:23 AM
RNS
Holding(s) in Company
03 Sep 2018 11:05 AM
RNS
Total Voting Rights
30 Aug 2018 09:58 AM
RNS
Holding(s) in Company
28 Aug 2018 12:45 PM
RNS
Holding(s) in Company
22 Aug 2018 09:41 AM
RNS
Director/PDMR Shareholding
15 Aug 2018 07:00 AM
RNS
Half-year Report
23 Jul 2018 09:00 AM
RNS
Notice of Results
09 Jul 2018 09:00 AM
RNS
Hikma enters licensing partnership with Perrigo
02 Jul 2018 04:56 PM
RNS
Total Voting Rights
15 Jun 2018 03:24 PM
RNS
Director/PDMR Shareholding
08 Jun 2018 11:50 AM
RNS
Director/PDMR Shareholding
04 Jun 2018 10:29 AM
RNS
Director/PDMR Shareholding
04 Jun 2018 09:00 AM
RNS
Hikma appoints Chief Transformation Officer
01 Jun 2018 11:34 AM
RNS
Total Voting Rights
30 May 2018 03:20 PM
RNS
Director/PDMR Shareholding
30 May 2018 09:00 AM
RNS
Hikma launches Methylergonovine Maleate Tablets
23 May 2018 10:20 AM
RNS
Director/PDMR Shareholding
18 May 2018 01:01 PM
RNS
AGM Results
18 May 2018 07:00 AM
RNS
Trading Statement
17 May 2018 01:45 PM
RNS
Director/PDMR Shareholding
17 May 2018 01:10 PM
RNS
Director/PDMR Shareholding
15 May 2018 02:26 PM
RNS
Director/PDMR Shareholding
03 May 2018 09:00 AM
RNS
Hikma launches Methotrexate Injection
01 May 2018 01:38 PM
RNS
Total Voting Rights
26 Apr 2018 01:40 PM
RNS
Holding(s) in Company
25 Apr 2018 10:41 AM
RNS
Block listing Interim Review
24 Apr 2018 09:00 AM
RNS
Hikma expands licensing agreement with Rovi
20 Apr 2018 09:00 AM
RNS
Hikma launches Dexrazoxane for Injection
19 Apr 2018 12:00 PM
RNS
Annual Financial Report and Notice of AGM

Hikma Pharmaceuticals is a British multinational pharmaceutical company, founded in 1978, that develops, manufactures, and markets a wide range of generic, branded, and in-licensed pharmaceutical products, with a focus on making high-quality medicines accessible.

Hikma share price launched at 281p in 2005.

 

UK 100

Latest directors dealings